miR-125b increases sensitivity of CD133+ colorectal cancer cells to cisplatin by down-regulating HAX-1 expression
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3969/j.issn.1000-4718.2017.06.016
   		
        
        	
        		- VernacularTitle:miR-125b通过下调HAX-1的表达提高CD133+SW480细胞对顺铂的敏感性
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Haiqiang PAN
			        		
			        		;
		        		
		        		
		        		
			        		Feng SHEN
			        		
			        		;
		        		
		        		
		        		
			        		Junhui CUI
			        		
			        		;
		        		
		        		
		        		
			        		Ke CAI
			        		
			        		;
		        		
		        		
		        		
			        		Zhijun DU
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		miR-125b;
			        		
			        		
			        		
				        		HAX-1;
			        		
			        		
			        		
				        		Cytochrome C;
			        		
			        		
			        		
				        		Cisplatin;
			        		
			        		
			        		
				        		CD133+ colorectal cancer cells
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Pathophysiology
	            		
	            		 2017;33(6):1053-1059
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	AIM:To investigate the role of miR-125b in regulating the sensitivity of CD133+ colorectal cancer cells to cisplatin.METHODS:The expression of miR-125b was detected by RT-qPCR in the routine SW480 cells and CD133+ SW480 cells.Flow cytometry analysis was performed to measure the percentage of CD133+ cell population in the SW480 cell line treated with miR-125b and cisplatin.MTT assay was performed to evaluate the effect of miR-125b on the cisplatin-induced cell death in the CD133+ SW480 cells.Bioinformatics and Western blot were performed to determine whether the expression of HAX-1 was regulated by miR-125b.JC-1 staining, Annexin V staining and Western blot analysis were used to study the pathway of apoptosis in the CD133+ SW480 cells co-treated with miR-125b and cisplatin.RESULTS:The expression of miR-125b was significantly lower in the CD133+ SW480 cells than that in the routine SW480 cells and normal colonic epithelial FHC cells.Treatment with cisplatin alone increased the percentage of CD133+ SW480 cell population.However, miR-125b significantly inhibited the enrichment of CD133+ cell population induced by cisplatin.In addition, the results of MTT assay showed that the anti-tumor effect of cisplatin was significantly enhanced when the miR-125b was transfected into the CD133+ SW480 cells.The results of Western blot indicated that the HAX-1 gene was the target of miR-125b.Furthermore, the apoptosis induced by the combination of miR-125b and cisplatin was dependent on the dysfunction of mitochondrial membrane, leading to the release of cytochrome C into the cytoplasm and the subsequently activation of apoptosis in the CD133+ SW480 cells.CONCLUSION:miR-125b increased the sensitivity of CD133+ colo-rectal cancer cells to cisplatin by down-regulating the expression of HAX-1.